The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Anti‐high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats
Abstract
The high mobility group box‐1 (HMGB1), originally identified as an architectural nuclear protein, exhibits an inflammatory cytokine‐like activity in the extracellular space. Here we show that treatment with neutralizing anti‐HMGB1 monoclonal antibody (mAb; 200 μg, twice) remarkably ameliorated brain infarction induced by 2‐h occlusion of the middle cerebral artery in rats, even when the mAb was administered after the start of reperfusion. Consistent with the 90% reduction in infarct size, the accompanying neurological deficits in locomotor function were significantly improved. Anti‐HMGB1 mAb inhibited the increased permeability of the blood‐brain barrier, the activation of microglia, the expression of TNF‐α and iNOS, and suppressed the activity of MMP‐9, whereas it had little effect on blood flow. Intracerebroventricular injection of HMGB1 increased the severity of infarction. Immunohistochemi‐cal studyrevealed that HMGB1 immunoreactivityin the cell nuclei decreased or disappeared in the affected areas, suggesting the release of HMGB1 into the extracellular space. These results indicate that HMGB1 plays a critical role in the development of brain infarction through the amplification of plural inflammatory responses in the ischemic region and could be an out‐standingly suitable target for the treatment. Intravenous injection of neutralizing anti‐HMGB1 mAb provides a novel therapeutic strategy for ischemic stroke.— Liu, K., Mori, S., Takahashi, H. K., Tomono, Y., Wake, H., Kanke, T., Sato, Y., Hiraga, N., Adachi, N., Yoshino, T., Nishibori, M. Anti‐high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats. FASEB J . 21, 3904–3916 (2007)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
HMG-1 as a Late Mediator of Endotoxin Lethality in Mice
Wang, H., Bloom, O., Zhang, M., Vishnubhakat, J. M., Ombrellino, M., Che, J., Frazier, A., Yang, H., Ivanova, S., Borovikova, L., et al. (1999) · Science · doi:10.1126/science.285.5425.248 · Cited by 3,385
Bederson, J. B., Pitts, L. H., Tsuji, M., Nishimura, M. C., Davis, R. L., & Bartkowski, H. (1986) · Stroke · doi:10.1161/01.str.17.3.472 · Cited by 2,681
High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal
Lotze, M. T., & Tracey, K. J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1594 · Cited by 2,487
Andersson, U., Wang, H., Palmblad, K., Aveberger, A.-C., Bloom, O., Erlandsson-Harris, H., Janson, A., Kokkola, R., Zhang, M., Yang, H., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.4.565 · Cited by 1,401
The Receptor for Advanced Glycation End Products (RAGE) Is a Cellular Binding Site for Amphoterin
Hori, O., Brett, J., Slattery, T., Cao, R., Zhang, J., Chen, J. X., Nagashima, M., Lundh, E. R., Vijay, S., Nitecki, D., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.43.25752 · Cited by 1,151
Reversing established sepsis with antagonists of endogenous high-mobility group box 1
Yang, H., Ochani, M., Li, J., Qiang, X., Tanovic, M., Harris, H. E., Susarla, S. M., Ulloa, L., Wang, H., DiRaimo, R., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2434651100 · Cited by 1,126
The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion
Tsung, A., Sahai, R., Tanaka, H., Nakao, A., Fink, M. P., Lotze, M. T., Yang, H., Li, J., Tracey, K. J., Geller, D. A., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042614 · Cited by 1,113
Yang, Y., Estrada, E. Y., Thompson, J. F., Liu, W., & Rosenberg, G. A. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600375 · Cited by 1,060
Asahi, M., Wang, X., Mori, T., Sumii, T., Jung, J.-C., Moskowitz, M. A., Fini, M. E., & Lo, E. H. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-19-07724.2001 · Cited by 1,004
High mobility group box 1 protein interacts with multiple Toll-like receptors
Park, J. S., Gamboni-Robertson, F., He, Q., Svetkauskaite, D., Kim, J.-Y., Strassheim, D., Sohn, J.-W., Yamada, S., Maruyama, I., Banerjee, A., et al. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00401.2005 · Cited by 932
Tumor Necrosis Factor-α: A Mediator of Focal Ischemic Brain Injury
Barone, F. C., Arvin, B., White, R. F., Miller, A., Webb, C. L., Willette, R. N., Lysko, P. G., & Feuerstein, G. Z. (1997) · Stroke · doi:10.1161/01.str.28.6.1233 · Cited by 863
HMGB1 SIGNALS THROUGH TOLL-LIKE RECEPTOR (TLR) 4 AND TLR2
Yu, M., Wang, H., Ding, A., Golenbock, D. T., Latz, E., Czura, C. J., Fenton, M. J., Tracey, K. J., & Yang, H. (2006) · Shock · doi:10.1097/01.shk.0000225404.51320.82 · Cited by 832
Cutting Edge: HMG-1 as a Mediator of Acute Lung Inflammation
Abraham, E., Arcaroli, J., Carmody, A., Wang, H., & Tracey, K. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.6.2950 · Cited by 692
HMG1 and 2, and related ‘architectural’ DNA-binding proteins
Thomas, J. O., & Travers, A. A. (2001) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(01)01801-1 · Cited by 618
Kim, J.-B., Sig Choi, J., Yu, Y.-M., Nam, K., Piao, C.-S., Kim, S.-W., Lee, M.-H., Han, P.-L., Park, J.-S., & Lee, J.-K. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3815-05.2006 · Cited by 579
The cytokine activity of HMGB1
Yang, H., Wang, H., Czura, C. J., & Tracey, K. J. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.1104648 · Cited by 545
Rock, C. S., & Lowry, S. F. (1991) · Journal of Surgical Research · doi:10.1016/0022-4804(91)90146-d · Cited by 503
Taniguchi, N., Kawahara, K., Yone, K., Hashiguchi, T., Yamakuchi, M., Goto, M., Inoue, K., Yamada, S., Ijiri, K., Matsunaga, S., et al. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10859 · Cited by 482
The ‘cytokine profile’: a code for sepsis
Ulloa, L., & Tracey, K. J. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.12.007 · Cited by 440
Sumii, T., & Lo, E. H. (2002) · Stroke · doi:10.1161/hs0302.104542 · Cited by 423
Gu, Z., Cui, J., Brown, S., Fridman, R., Mobashery, S., Strongin, A. Y., & Lipton, S. A. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1563-05.2005 · Cited by 417
Inhibition of inducible nitric oxide synthase ameliorates cerebral ischemic damage
Iadecola, C., Zhang, F., & Xu, X. (1995) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1995.268.1.r286 · Cited by 362
Contributions of High Mobility Group Box Protein in Experimental and Clinical Acute Lung Injury
Ueno, H., Matsuda, T., Hashimoto, S., Amaya, F., Kitamura, Y., Tanaka, M., Kobayashi, A., Maruyama, I., Yamada, S., Hasegawa, N., et al. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200402-188oc · Cited by 355
HMGB1: guiding immunity from within
Dumitriu, I. E., Baruah, P., Manfredi, A. A., Bianchi, M. E., & Rovere-Querini, P. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.04.009 · Cited by 340
Kokkola, R., Li, J., Sundberg, E., Aveberger, A. ‐., Palmblad, K., Yang, H., Tracey, K. J., Andersson, U., & Harris, H. E. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11161 · Cited by 325
Monoclonal antibodies as therapeutic agents for cancer
Harris, M. (2004) · The Lancet Oncology · doi:10.1016/s1470-2045(04)01467-6 · Cited by 320
Gregersen, R., Lambertsen, K., & Finsen, B. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200001000-00009 · Cited by 314
Regulation of monocyte migration by amphoterin (HMGB1)
Rouhiainen, A. (2004) · Blood · doi:10.1182/blood-2003-10-3536 · Cited by 250
Merenmies, J., Pihlaskari, R., Laitinen, J., Wartiovaara, J., & Rauvala, H. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55361-8 · Cited by 242
The Neurotoxicity of Tissue Plasminogen Activator?
Kaur, J., Zhao, Z., Klein, G. M., Lo, E. H., & Buchan, A. M. (2004) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000137868.50767.e8 · Cited by 242
Shimazu, T., Inoue, I., Araki, N., Asano, Y., Sawada, M., Furuya, D., Nagoya, H., & Greenberg, J. H. (2005) · Stroke · doi:10.1161/01.str.0000152271.21943.a2 · Cited by 218
Parkkinen, J., Raulo, E., Merenmies, J., Nolo, R., Kajander, E. O., Baumann, M., & Rauvala, H. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36575-5 · Cited by 216
Rauvala, H., & Pihlaskari, R. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)49302-7 · Cited by 210
Aoki, T., Sumii, T., Mori, T., Wang, X., & Lo, E. H. (2002) · Stroke · doi:10.1161/01.str.0000033932.34467.97 · Cited by 206
Han, H. S., Qiao, Y., Karabiyikoglu, M., Giffard, R. G., & Yenari, M. A. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-10-03921.2002 · Cited by 191
Milev, P., Chiba, A., Häring, M., Rauvala, H., Schachner, M., Ranscht, B., Margolis, R. K., & Margolis, R. U. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.12.6998 · Cited by 190
Phillips, J. B., Williams, A. J., Adams, J., Elliott, P. J., & Tortella, F. C. (2000) · Stroke · doi:10.1161/01.str.31.7.1686 · Cited by 182
Antibody to the α4 Integrin Decreases Infarct Size in Transient Focal Cerebral Ischemia in Rats
Becker, K., Kindrick, D., Relton, J., Harlan, J., & Winn, R. (2001) · Stroke · doi:10.1161/01.str.32.1.206 · Cited by 168
Effect of MCI-186 on brain edema in rats.
Nishi, H., Watanabe, T., Sakurai, H., Yuki, S., & Ishibashi, A. (1989) · Stroke · doi:10.1161/01.str.20.9.1236 · Cited by 163
Matsuo, Y., Mihara, S., Ninomiya, M., & Fujimoto, M. (2001) · Stroke · doi:10.1161/hs0901.94259 · Cited by 128
Zhao, B., Ikeda, Y., Ihara, H., Urano, T., Fan, W., Mikawa, S., Suzuki, Y., Kondo, K., Sato, K., Nagai, N., et al. (2003) · Blood · doi:10.1182/blood-2003-03-0835 · Cited by 80
Pedrazzi, M., Raiteri, L., Bonanno, G., Patrone, M., Ledda, S., Passalacqua, M., Milanese, M., Melloni, E., Raiteri, M., Pontremoli, S., et al. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04120.x · Cited by 73
Effect of MK-801 on focal brain infarction in normotensive and hypertensive rats.
Roussel, S., Pinard, E., & Seylaz, J. (1992) · Hypertension · doi:10.1161/01.hyp.19.1.40 · Cited by 58
SLEVIN, M. A., Krupiński, J., Kumar, P., Gaffney, J. J., & Kumar, S. (2005) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2005.tb00339.x · Cited by 55
The search for neuroprotective strategies in stroke.
Danton, G. H., & Dietrich, W. D. (2004) · PubMed · Cited by 53
Hiraga, N., Adachi, N., Liu, K., Nagaro, T., & Arai, T. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.11.020 · Cited by 48
Self-citationMaeda, M., Furuichi, Y., Ueyama, N., Moriguchi, A., Satoh, N., Matsuoka, N., Goto, T., & Yanagihara, T. (2002) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000037993.34930.72 · Cited by 42
Ren, D. C., Sun, R., & Wang, S. (2006) · Inflammation Research · doi:10.1007/s00011-006-0072-2 · Cited by 39
Emerging biologic therapies in rheumatoid arthritis: cell targets and cytokines
Singh, R., Robinson, D. B., & El-Gabalawy, H. S. (2005) · Current Opinion in Internal Medicine · doi:10.1097/01.bor.0000160778.05389.dc · Cited by 31
Cited by
HMGB1 is a therapeutic target for sterile inflammation and infection
Andersson, U., & Tracey, K. J. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101323 · Cited by 1,437
Kang, R., Chen, R., Zhang, Q., Hou, W., Wu, S., Cao, L., Huang, J., Yu, Y., Fan, X.-G., Yan, Z., et al. (2014) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2014.05.001 · Cited by 956
DAMPening Inflammation by Modulating TLR Signalling
Piccinini, A. M., & Midwood, K. S. (2010) · Mediators of Inflammation · doi:10.1155/2010/672395 · Cited by 973
The immunology of acute stroke
Chamorro, Á., Meisel, A., Planas, A. M., Urra, X., van de Beek, D., & Veltkamp, R. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.98 · Cited by 707
A Review of Neutrophil Extracellular Traps (NETs) in Disease: Potential Anti-NETs Therapeutics
Mutua, V., & Gershwin, L. J. (2021) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-020-08804-7 · Cited by 639
Metadata
- Authors
- Liu, K., Mori, S., Takahashi, H. K., Tomono, Y., Wake, H., Kanke, T., Sato, Y., Hiraga, N., Adachi, N., Yoshino, T., & Nishibori, M.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2007-07-12
- Volume
- 21
- Issue
- 14
- Pages
- 3904-3916
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2149240296
- Cited by
- 366
- References
- 49
- FWCI
- 10.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.